Select for export From efficacy to effectiveness: evaluating psychedelic randomised controlled trials for trustworthy evidence-based policy and practice. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.31234/osf.io/uxhv7 Copy citation Copy BibTeX PsyArXiv 2024-09-30 Schenberg EE. PsyArXiv PREPRINT (not peer reviewed) psilocybin DepressionPTSDRandomized Controlled Trial Randomized Controlled Trial More
Select for export From efficacy to effectiveness: evaluating psychedelic randomised controlled trials for trustworthy evidence-based policy and practice. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.31234/osf.io/uxhv7_v1 Copy citation Copy BibTeX PsyArXiv 2024-09-30 Schenberg EE. PsyArXiv PREPRINT (not peer reviewed) psilocybin DepressionPTSDRandomized Controlled Trial Randomized Controlled Trial More
Select for export Artificial intelligence and psychedelic medicine. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1111/nyas.15229 PubMed 39308441 Copy citation Copy BibTeX Annals of the New York Academy of Sciences 2024-09-30 Sarris J, Halman A, Urokohara A, Lehrner M, Perkins D PubMed Published psilocybin PharmacologyClinical TrialReview Article Clinical Trial More
Select for export What do health professionals think about implementing psilocybin-assisted therapy in palliative care for existential distress? A World Café qualitative study Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1017/s1478951524001494 PubMed 39379285 Copy citation Copy BibTeX Palliative & Supportive Care 2024-09-30 Marianne Masse-Grenier, Sue-Ling Chang, Ariane Bélanger, Jean-François Stephan, Johanne Hébert, P. Deschamps OpenAlex Published psilocybin End-of-Life DistressToxicity Qualitative Study More
Select for export From efficacy to effectiveness: evaluating psychedelic randomised controlled trials for trustworthy evidence-based policy and practice. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1002/prp2.70097 Copy citation Copy BibTeX PsyArXiv 2024-09-30 Authors unavailable PsyArXiv PREPRINT (not peer reviewed) psilocybin DepressionPTSDRandomized Controlled Trial Randomized Controlled Trial More
Select for export Psilocybin increases optimistic engagement over time: computational modelling of behaviour in rats Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41398-024-03103-7 PubMed 39349428 Copy citation Copy BibTeX Translational Psychiatry 2024-09-29 Elizabeth L. Fisher, Ryan Smith, Kyna-Anne Conn, Andrew W. Corcoran, Laura K Milton, Jakob Hohwy OpenAlex Published psilocybin DepressionMechanism of ActionReceptor Pharmacology Clinical Trial More
Select for export What should constitute a control condition in psychedelic drug trials? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s44220-024-00321-2 PubMed 39781538 Copy citation Copy BibTeX Unknown journal 2024-09-29 Colloca L, Fava M. Europe PMC Published psilocybin General Other More
Select for export Harnessing Pharmacogenomics in Clinical Research on Psychedelic-Assisted Therapy. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1002/cpt.3459 PubMed 39345195 Copy citation Copy BibTeX Unknown journal 2024-09-29 Halman A, Conyers R, Moore C, Khatri D, Sarris J, Perkins D. Europe PMC Published psilocybin PharmacologyReview ArticleAnimal Study Review Article More
Select for export The Action on Psilocybin in Neural Plasticity, Brain Reorganization and Cognitive Enhancement Abstract available at the source but not redistributed here. Read at source. Details DOI 10.36348/merjbs.2024.v04i05.001 Copy citation Copy BibTeX Middle East Research Journal of Biological Sciences 2024-09-27 Carlos Henrique Marchiori, Marco Vinícios de Oliveira Santana, Klebert de Paula Malheiros OpenAlex Published psilocybinpsilocin DepressionAnxietyAddiction Review Article More
Select for export The Effects of Psilocybin on Shared Experience in Film Processing Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2024-09-26 Western University, Canada ClinicalTrials.gov CLINICAL TRIAL psilocybin Brain ImagingConsciousnessAging Clinical Trial More
Select for export Meditating on psychedelics. A randomized placebo-controlled study of DMT and harmine in a mindfulness retreat Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811241282637 PubMed 39340164 Copy citation Copy BibTeX Journal of Psychopharmacology 2024-09-26 Daniel Meling, Klemens Egger, Helena Aicher, Javier Jareño Redondo, Jovin Mueller, Joëlle Dornbierer OpenAlex Published psilocybin Chronic PainWellbeingEmotional Processing Clinical Trial More
Select for export Single-dose psilocybin for U.S. military Veterans with severe treatment-resistant depression - A first-in-kind open-label pilot study No abstract availability was recorded for this entry. Details DOI 10.1016/j.jad.2024.09.133 PubMed 39343309 Copy citation Copy BibTeX Journal of Affective Disorders 2024-09-26 Sara Ellis, Catherine Bostian, Wendy Feng, E. Grace Fischer, Garrett Schwartz, Katherine Eisen OpenAlex Published psilocybin DepressionChronic PainClinical Trial Clinical Trial More
Select for export Salience, sensemaking, and setting in psilocybin microdosing: Methodological lessons and preliminary findings of a mixed method qualitative study Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/09515089.2024.2393690 Copy citation Copy BibTeX Philosophical Psychology 2024-09-25 Aleš Oblak, Liam Korošec Hudnik, Anja Levačić, Kristian Elersič, Peter Pregelj, Jurij Bon OpenAlex Published psilocybin ConsciousnessMicrodosing Qualitative Study More
Select for export An Open-Label Pilot Study Examining the Feasibility, Safety, and Effectiveness of Psilocybin Therapy for Depression in Bipolar II Disorder Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2024-09-24 University of California, San Francisco ClinicalTrials.gov CLINICAL TRIAL psilocybin DepressionHealthcare WorkersSafety Other More
Select for export Psychedelics as novel therapeutic agents for chronic pain: mechanisms and future perspectives Abstract available at the source but not redistributed here. Read at source. Details DOI 10.37349/en.2024.00058 Copy citation Copy BibTeX Exploration of neuroscience 2024-09-23 Bushra Yasin, Shivani Mehta, George Tewfik, Alex Bekker OpenAlex Published psilocybin AddictionChronic PainNeuroplasticity Review Article More
Select for export Single-dose psilocybin alters resting state functional networks in patients with body dysmorphic disorder Abstract available at the source but not redistributed here. Read at source. Details DOI 10.61373/pp024r.0028 PubMed 40458078 Copy citation Copy BibTeX Psychedelics. 2024-09-23 Xi Zhu, Chen Zhang, David J. Hellerstein, Jamie D. Feusner, Michael G. Wheaton, Gloria J. Gomez OpenAlex Published psilocybin DepressionBrain ImagingReceptor Pharmacology Other More
Select for export Psilocybin legalization in the United States and psychological reactance: A test of evidence uncertainty, controlling language, and an ambiguous call to action. No abstract availability was recorded for this entry. Details DOI 10.1037/mot0000361 Copy citation Copy BibTeX Motivation Science 2024-09-22 Brian L. Quick, Ethan Morrow, Sam R. Wilson, Minhey Chung, Daniel E. Hartman, Brenda Koester OpenAlex Published psilocybin General Other More
Select for export Psilocybin for major depressive disorder: a systematic review of randomized controlled studies. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2024.1416420 PubMed 39376971 Copy citation Copy BibTeX Unknown journal 2024-09-22 Li LJ, Mo Y, Shi ZM, Huang XB, Ning YP, Wu HW Europe PMC Published psilocybin DepressionAnxietyHeadache / Migraine Randomized Controlled Trial More
Select for export Effect of psilocybin versus escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder: observational 6-month follow-up of a phase 2, double-blind, randomised, controlled trial Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.eclinm.2024.102799 PubMed 39764567 Copy citation Copy BibTeX EClinicalMedicine 2024-09-22 David Erritzøe, Tommaso Barba, Kyle T. Greenway, Roberta Murphy, Jonny Martell, Bruna Giribaldi OpenAlex Published psilocybin DepressionAnxietyChronic Pain Randomized Controlled Trial More
Select for export Acute psilocybin and ketanserin effects on cerebral blood flow: 5-HT2AR neuromodulation in healthy humans Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1101/2024.09.19.24313958 Copy citation Copy BibTeX medRxiv 2024-09-21 Larsen K, Lindberg U, Ozenne B, McCulloch DE, Armand S, Madsen MK medRxiv PREPRINT (not peer reviewed) psilocybinpsilocin DepressionBrain ImagingReceptor Pharmacology Other More
